Women were less likely than men to be treated for relapsing multiple sclerosis (MS), French registry data showed. Women had a ...

A pioneering study presented today at ECTRIMS 2024 has identified critical biomarkers that can predict disability worsening in multiple sclerosis (MS).

Early, aggressive treatment of brain lesions caused by multiple sclerosis could help ward off faster decline in patients, a ...

Researchers have identified biomarkers that can predict disease progression in multiple sclerosis, which could lead to the ...

A study has revealed significant therapeutic inertia in the treatment of women with multiple sclerosis (MS), highlighting gender disparities that could impact long-term health outcomes for women of ...

Sanofi’s experimental drug for a form of multiple sclerosis delayed the progression of disability by nearly a third, ...

Rutgers Health researchers will enroll primary or secondary progressive multiple sclerosis (p-MS) patients to see if an ...

The catering manager for a local secondary school explained that making the decision to receive cold cap treatment was one of ...

The online program "Eating Well with MS" improved dietary behavior among multiple sclerosis patients and was deemed valuable, ...

Patients with MS showed half the rate of amyloid pathology compared with people without MS, suggesting a possible protective ...

New research presented today at European Committee for Treatment and Research in Multiple Sclerosis 2024 reveals that ...

Tolebrutinib delayed the onset of disability progression by 31% for patients with a type of the disease called non-relapsing ...